Taste conditioning effects of buprenorphine in morphine-naive and morphine-experienced rats

Pharmacological Research

Volumn 37, Issue 4, 1998, Pages 303-307

  Gaiardi, M ^a   Gubellini, C ^a   Bartoletti, M ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Buprenorphine; d amphetamine; Morphine preexposure; Taste aversion

Indexed keywords

BUPRENORPHINE; DEXAMPHETAMINE; MORPHINE; SACCHARIN;

ANIMAL EXPERIMENT; ARTICLE; CONDITIONING; CONTROLLED STUDY; DRUG ABUSE; DRUG EFFECT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TASTE;

EID: 0032055999     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1998.0303     Document Type: Article

References (25)

1. 1. Brown EE, Finlay JM, Wong JZF, Damsma G, Fibiger HC. Behavioral and neurochemical interactions between cocaine and buprenorphine: implications for the pharmacotherapy of cocaine abuse. J Pharmacol Exp Ther 1991; 256: 119-26.
2. 2. Pchelintsev MV, Gorbacheva EN, Zvartau EE. Simple methodology of assessment of analgesics' addictive potential in mice. Pharmacol Biochem Behav 1991; 39: 873-6.
3. 3. Rowlett JK, Gibson TR, Bardo MT. Dissociation of buprenorphine-induced locomotor sensitization and conditioned place preference. Pharmacol Biochem Behav 1994; 49: 241-5.
4. 4. Gaiardi M, Bartoletti M, Bacchi A, Gubellini C, Babbini M. Motivational properties of buprenorphine as assessed by place and taste conditioning in rats. Psychopharmacology 1997; 130: 104-8.
5. 5. Goudie AJ. Aversive stimulus properties of drugs: the conditioned taste aversion paradigm. In: Greenshaw AJ, Dourish CT, eds. Experimental Psychopharmacology. Clifton: Humana Press, 1987: pp. 341-91.
6. 6. Hunt T, Amit Z. Conditioned taste aversion induced by self-administered drugs: paradox revisited. Neurosci Biobehav Rev 1987; 11: 107-30.
7. 7. van Haaren F, Hughes CE. Cocaine-induced conditioned taste aversions in male and female Wistar rats. Pharmacol Biochem Behav 1990; 37: 693-6.
8. 8. Calcagnetti DJ, Reid LD. Morphine and acceptability of putative reinforcers. Pharmacol Biochem Behav 1983; 18: 567-9.
9. 9. Touzani K, Velley L. Ibotenic acid lesion of the lateral hypothalamus increases preference and aversion thresholds for saccharin and alters the morphine modulation of taste. Pharmacol Biochem Behav 1990; 36: 585-91.
10. 10. Stewart J, Eikelboom R. Pre-exposure to morphine and the attenuation of conditioned taste aversion in rats. Pharmacol Biochem Behav 1978; 9: 639-45.
11. 11. Martin GM, Bechara A, van der Kooy D. Morphine preexposure attenuates the aversive properties of opiates without preexposure to the aversive properties. Pharmacol Biochem Behav 1988; 30: 687-92.
12. 12. Gaiardi M, Bartoletti M, Bacchi A, Gubellini C, Costa M, Babbini M. Role of repeated exposures to morphine in determining its affective properties: place and taste conditioning studies in rats. Psychopharmacology 1991; 103: 183-6.
13. 13. Vogel JR, Bernard B, Donald EC. A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacologia 1971; 21: 1-7.
14. 14. Jacobs WJ, Zellner DA, Lo Lordo VM, Riley AL. The effect of post-conditioning exposure to morphine on the retention of a morphine-induced conditioned taste aversion. Pharmacol Biochem Behav 1981; 14: 779-85.
15. 15. Greenshaw AJ, Dourish CT. Differential aversive stimulus properties of β-phenylethylamine and of d-amphetamine. Psychopharmacology 1984; 82: 189-93.
16. 16. Gaiardi M, Bartoletti M, Gubellini C, Bacchi A, Babbini M. Modulation of the stimulus effects of morphine by d-amphetamine. Pharmacol Biochem Behav 1998; 59: 249-53.
17. 17. Shippenberg TS. Motivational effects of opiods. In: Herz A, ed. Handbook of Experimental Pharmacology. Berlin: Springer Verlag, 1993; 104/II: 633-50.
18. 18. Reisine T, Pasternak G. Opioid analgesics and antagonists. In: Houdman JG, Goodman Gilman A, Limbird LE, eds. Goodman and Gilman's: The Pharmacological Basis of Therapeutics. New York: Pergamon Press, 1996: pp. 521-55.
19. 19. Gilbert D, Cooper SJ. β-phenylethylamine-, d-amphetamine- and 1-amphetamine-induced place preference conditioning in rats. Eur J Pharmacol 1983; 95: 311-14.
20. 20. Rabin BM, Hunt WA, Lee J. Attenuation and cross-attenuation in taste aversion learning in the rat: studies with ionizing radiation, lithium chloride and ethanol. Pharmacol Biochem Behav 1989; 31: 909-18.
21. 21. Picker MJ, Yarbrough J, Hughes CE, Smith MA, Morgan D, Dykstra L. Agonist and antagonist effects of mixed action opioids in the pigeon drug discrimination procedure: influence of training dose, intrinsic efficacy and interanimal differences. J Pharmacol Exp Ther 1993; 266: 756-67.
22. 22. Gauvin DV, Young AM. Evidence for perceptual masking of the discriminative morphine stimulus. Psychopharmacology 1989; 98: 212-21.
23. 23. Jasinski DR, Fudala PJ, Johnson RE. Sublingual versus subcutaneous buprenorphine in opiate abusers. Clin Pharmacol Ther 1989; 45: 513-19.
24. 24. Stolerman I. Drugs of abuse: behavioral principles, methods and terms. Trends Pharmacol Sci 1992; 13: 170-6.
25. 25. San L, Torrens M, Castillo C, Porte M, De La Torre R. Consumption of buprenorphine and other drugs among heroin addicts under ambulatory treatment: results from cross-sectional studies in 1988 and 1990. Addiction 1993; 88: 1341-9.